DNA多态性在两个paraoxonase基因(PON1和PON2)与冠心病的风险。

文章的细节

引用

桑赫拉DK,阿斯顿CE、萨哈N, Kamboh MI

DNA多态性在两个paraoxonase基因(PON1和PON2)与冠心病的风险。

J哼麝猫。1998年1月,62 (1):36-44。

PubMed ID
9443862 (在PubMed
]
文摘

共同多态性在密码子192年人类paraoxonase(其)1基因已被证明是与风险增加有关高加索人群的冠心病(CHD)。然而,这些发现还没有报道持续在所有白人和白人人口,这表明这不是一个功能性突变但可能标志着功能性突变出现在PON1或附近的一个基因。最近,另外两个PON-like基因,指定“PON2”和“PON3”,已确定,并与已知PON1 7号染色体上的基因。识别额外的多态性PON-gene集群有助于定位功能多态性。在这个报告中,我们描述一个共同多态性的存在在密码子311(半胱氨酸- - > Ser;PON2 PON2基因*年代),以及其与冠心病和结合PON1 192密码子多态性在亚洲印度人。PON2 * S等位基因的频率明显高于比在控制(在这种情况下。71与点;P = .016)。的年龄和sex-adjusted比值比(或)为2.5(95%置信区间&sqbl0; 95% CI&sqbr0; = 1.8 - -3.1;P = .0090) PON2 * S等位基因携带者。 Further stratification of the PON2*S association, on the basis of the presence or absence of the PON1*B allele, showed that the CHD risk associated with the PON2*S allele was confined to PON1*B-allele carriers. Likewise, the PON1*B-allele risk was present only among PON2*S carriers. Age- and sex-adjusted ORs for the PON2*S and PON1*B were 3.6 (95% CI=2.6-4.6; P=.011) and 2.9 (95% CI=2.4-3.5; P=.0002) among the PON1*B and PON2*S carriers, respectively. Our data indicate that both polymorphisms synergistically contribute to the CHD risk in this sample and that this genetic risk is independent of the conventional plasma lipid profile.

DrugBank数据引用了这篇文章

多肽
的名字 UniProt ID
血清paraoxonase /芳香酯2 Q15165 细节